{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T07:52:10Z","timestamp":1781596330527,"version":"3.54.5"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"The state assignment of Lomonosov Moscow State University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pflugers Arch - Eur J Physiol"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s00424-026-03181-0","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T01:01:16Z","timestamp":1779238876000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Chronic atorvastatin treatment weakens procontractile influence of NADPH oxidase derived ROS in systemic murine arteries"],"prefix":"10.1007","volume":"478","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8859-7689","authenticated-orcid":false,"given":"Anastasia A.","family":"Shvetsova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2949-0026","authenticated-orcid":false,"given":"Guzalia F.","family":"Zakirjanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kseniia P.","family":"Ostapchuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1432-3455","authenticated-orcid":false,"given":"Alexey M.","family":"Petrov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5104-2399","authenticated-orcid":false,"given":"Dina K.","family":"Gaynullina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,20]]},"reference":[{"key":"3181_CR1","doi-asserted-by":"publisher","first-page":"e0220473","DOI":"10.1371\/journal.pone.0220473","volume":"14","author":"M Absi","year":"2019","unstructured":"Absi M, Eid BG, Ashton N, Hart G, Gurney AM (2019) Simvastatin causes pulmonary artery relaxation by blocking smooth muscle ROCK and calcium channels: Evidence for an endothelium-independent mechanism. PLoS ONE 14:e0220473. https:\/\/doi.org\/10.1371\/journal.pone.0220473","journal-title":"PLoS ONE"},{"key":"3181_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/pds.5879","volume":"33","author":"SA Ageeb","year":"2024","unstructured":"Ageeb SA, Abdelmoghith A, ElGeed H, Awaisu A, ElMansor A, Owusu YB (2024) Prevalence, associated risk factors, and adverse cardiovascular outcomes of statins discontinuation: A systematic review. Pharmacoepidemiol Drug Saf 33:1\u201330. https:\/\/doi.org\/10.1002\/pds.5879","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"3181_CR3","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1111\/fcp.12173","volume":"30","author":"F\u0130 Alp Yildirim","year":"2016","unstructured":"Alp Yildirim F\u0130, Kaleli Durman D, Aypar E, Ark M, \u00d6zdemir O, Uyde\u015f Do\u011fan BS (2016) Atorvastatin acutely reduces the reactivity to spasmogens in rat aorta: Implication of the inhibition of geranylgeranylation and MYPT-1 phosphorylation. Fundam Clin Pharmacol 30:96\u2013106. https:\/\/doi.org\/10.1111\/fcp.12173","journal-title":"Fundam Clin Pharmacol"},{"key":"3181_CR4","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1161\/HYPERTENSIONAHA.109.133710","volume":"54","author":"AM Briones","year":"2009","unstructured":"Briones AM, Rodr\u00edguez-Criado N, Hernanz R, Garc\u00eda-Redondo AB, Rodrigues-D\u00edez RR, Alonso MJ, Egido J, Ruiz-Ortega M, Salaices M (2009) Atorvastatin prevents angiotensin II\u2013induced vascular remodeling and oxidative stress. Hypertension 54:142\u2013149. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.109.133710","journal-title":"Hypertension"},{"key":"3181_CR5","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.clinbiochem.2007.03.016","volume":"40","author":"I Buhaescu","year":"2007","unstructured":"Buhaescu I, Izzedine H (2007) Mevalonate pathway: A review of clinical and therapeutical implications. Clin Biochem 40:575\u2013584. https:\/\/doi.org\/10.1016\/j.clinbiochem.2007.03.016","journal-title":"Clin Biochem"},{"key":"3181_CR6","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1002\/ppul.23610","volume":"52","author":"I Chen","year":"2017","unstructured":"Chen I, Tan M, Wu B, Chai C, Yeh J, Chou S, Chen I, Dai Z (2017) Statins ameliorate pulmonary hypertension secondary to left ventricular dysfunction through the Rho-kinase pathway and NADPH oxidase. Pediatr Pulmonol 52:443\u2013457. https:\/\/doi.org\/10.1002\/ppul.23610","journal-title":"Pediatr Pulmonol"},{"key":"3181_CR7","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1111\/j.1476-5381.2012.02106.x","volume":"169","author":"R Colucci","year":"2013","unstructured":"Colucci R, Fornai M, Duranti E, Antonioli L, Rugani I, Aydinoglu F, Ippolito C, Segnani C, Bernardini N, Taddei S, Blandizzi C, Virdis A (2013) Rosuvastatin prevents angiotensin-induced vascular changes by inhibition of NADPH oxidase and COX\u20101. Br J Pharmacol 169:554\u2013566. https:\/\/doi.org\/10.1111\/j.1476-5381.2012.02106.x","journal-title":"Br J Pharmacol"},{"key":"3181_CR8","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1254\/jphs.09148FP","volume":"111","author":"W Cui","year":"2009","unstructured":"Cui W, Matsuno K, Iwata K, Ibi M, Katsuyama M, Kakehi T, Sasaki M, Ikami K, Zhu K, Yabe-Nishimura C (2009) NADPH Oxidase isoforms and anti-hypertensive effects of atorvastatin demonstrated in two animal models. J Pharmacol Sci 111:260\u2013268. https:\/\/doi.org\/10.1254\/jphs.09148FP","journal-title":"J Pharmacol Sci"},{"key":"3181_CR9","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1161\/01.cir.0000131517.20177.5a","volume":"109","author":"J Davignon","year":"2004","unstructured":"Davignon J (2004) Beneficial cardiovascular pleiotropic effects of statins. Circulation 109:39\u201343. https:\/\/doi.org\/10.1161\/01.cir.0000131517.20177.5a","journal-title":"Circulation"},{"key":"3181_CR10","doi-asserted-by":"publisher","first-page":"H1264","DOI":"10.1152\/ajpheart.00804.2005","volume":"290","author":"B Erd\u00f6s","year":"2006","unstructured":"Erd\u00f6s B, Snipes JA, Tulbert CD, Katakam P, Miller AW, Busija DW (2006) Rosuvastatin improves cerebrovascular function in Zucker obese rats by inhibiting NAD(P)H oxidase-dependent superoxide production. Am J Physiol Circ Physiol 290:H1264\u2013H1270. https:\/\/doi.org\/10.1152\/ajpheart.00804.2005","journal-title":"Am J Physiol Circ Physiol"},{"key":"3181_CR11","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.amjcard.2020.06.006","volume":"130","author":"D Fabijanic","year":"2020","unstructured":"Fabijanic D, Luksic B, Ljubkovic M (2020) Statins in primary prevention of cardiovascular disease \u2013 should we start while young and healthy? Am J Cardiol 130:165\u2013166. https:\/\/doi.org\/10.1016\/j.amjcard.2020.06.006","journal-title":"Am J Cardiol"},{"key":"3181_CR12","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/j.1474-8673.1984.tb00093.x","volume":"4","author":"ED H\u00f6gest\u00e4tt","year":"1984","unstructured":"H\u00f6gest\u00e4tt ED, Andersson K-E (1984) On the postjunctional alpha-adrenoreceptors in rat cerebral and mesenteric arteries. J Auton Pharmacol 4:161\u2013175. https:\/\/doi.org\/10.1111\/j.1474-8673.1984.tb00093.x","journal-title":"J Auton Pharmacol"},{"key":"3181_CR13","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1111\/j.1748-1716.2011.02403.x","volume":"205","author":"K Ishida","year":"2012","unstructured":"Ishida K, Matsumoto T, Taguchi K, Kamata K, Kobayashi T (2012) Pravastatin normalizes endothelium-derived contracting factor\u2010mediated response via suppression of <\u2009scp>R ho\u2010kinase signalling in mesenteric artery from aged type 2 diabetic rat. Acta Physiol 205:255\u2013265. https:\/\/doi.org\/10.1111\/j.1748-1716.2011.02403.x","journal-title":"Acta Physiol"},{"key":"3181_CR14","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1111\/j.1440-1681.2006.04430.x","volume":"33","author":"Y Kansui","year":"2006","unstructured":"Kansui Y, Fujii K, Goto K, Oniki H, Iida M, CHRONic fluvastatin treatment alters vascular contraction by inhibiting the rho\/rho-kinase pathway (2006) Clin Exp Pharmacol Physiol 33:673\u2013678. https:\/\/doi.org\/10.1111\/j.1440-1681.2006.04430.x","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"3181_CR15","doi-asserted-by":"publisher","first-page":"5401","DOI":"10.1113\/jphysiol.2012.241315","volume":"590","author":"T Kitazawa","year":"2012","unstructured":"Kitazawa T, Kitazawa K (2012) Size-dependent heterogeneity of contractile Ca2\u2009+\u2009sensitization in rat arterial smooth muscle. J Physiol 590:5401\u20135423. https:\/\/doi.org\/10.1113\/jphysiol.2012.241315","journal-title":"J Physiol"},{"key":"3181_CR16","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.freeradbiomed.2019.09.029","volume":"145","author":"GA Knock","year":"2019","unstructured":"Knock GA (2019) NADPH oxidase in the vasculature: Expression, regulation and signalling pathways; role in normal cardiovascular physiology and its dysregulation in hypertension. Free Radic Biol Med 145:385\u2013427. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2019.09.029","journal-title":"Free Radic Biol Med"},{"key":"3181_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/10641963.2017.1313849","volume":"00","author":"W Liu","year":"2018","unstructured":"Liu W, Xu X, Luo Q, Zhang H, Wang Y (2018) Inhibition of the RhoA \/ Rho-associated, coiled-coil- containing protein kinase-1 pathway is involved in the therapeutic effects of simvastatin on pulmonary arterial hypertension. Clin Exp Hypertens 00:1\u20137. https:\/\/doi.org\/10.1080\/10641963.2017.1313849","journal-title":"Clin Exp Hypertens"},{"key":"3181_CR18","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1097\/FJC.0b013e318250ba2c","volume":"59","author":"M Ma","year":"2012","unstructured":"Ma M, Li S, Wang M, Guan Y (2012) Simvastatin Attenuated Cerebrovascular Cell Proliferation in the Development of Hypertension Through Rho\/Rho-kinase Pathway. J Cardiovasc Pharmacol 59:576\u2013582. https:\/\/doi.org\/10.1097\/FJC.0b013e318250ba2c","journal-title":"J Cardiovasc Pharmacol"},{"key":"3181_CR19","doi-asserted-by":"publisher","first-page":"8643","DOI":"10.1007\/s12035-019-01696-5","volume":"56","author":"G Mohammad","year":"2019","unstructured":"Mohammad G, Duraisamy AJ, Kowluru A, Kowluru RA (2019) Functional regulation of an oxidative stress mediator, Rac1, in diabetic retinopathy. Mol Neurobiol 56:8643\u20138655. https:\/\/doi.org\/10.1007\/s12035-019-01696-5","journal-title":"Mol Neurobiol"},{"key":"3181_CR20","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1161\/01.RES.41.1.19","volume":"41","author":"MJ Mulvany","year":"1977","unstructured":"Mulvany MJ, Halpern W (1977) Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res 41:19\u201326. https:\/\/doi.org\/10.1161\/01.RES.41.1.19","journal-title":"Circ Res"},{"key":"3181_CR21","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1167\/iovs.06-0856","volume":"48","author":"T Nagaoka","year":"2007","unstructured":"Nagaoka T, Hein TW, Yoshida A, Kuo L (2007) Simvastatin elicits dilation of isolated porcine retinal arterioles: Role of nitric oxide and mevalonate-rho kinase pathways. Investig Opthalmology Vis Sci 48:825. https:\/\/doi.org\/10.1167\/iovs.06-0856","journal-title":"Investig Opthalmology Vis Sci"},{"key":"3181_CR22","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4103\/0976-0105.177703","volume":"7","author":"A Nair","year":"2016","unstructured":"Nair A, Jacob S (2016) A simple practice guide for dose conversion between animals and human. J Basic Clin Pharm 7:27. https:\/\/doi.org\/10.4103\/0976-0105.177703","journal-title":"J Basic Clin Pharm"},{"key":"3181_CR23","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.amjcard.2008.10.008","volume":"103","author":"R Rawlings","year":"2009","unstructured":"Rawlings R, Nohria A, Liu P-Y, Donnelly J, Creager MA, Ganz P, Selwyn A, Liao JK (2009) Comparison of effects of rosuvastatin (10 mg) versus atorvastatin (40 mg) on Rho kinase activity in caucasian men with a previous atherosclerotic event. Am J Cardiol 103:437\u2013441. https:\/\/doi.org\/10.1016\/j.amjcard.2008.10.008","journal-title":"Am J Cardiol"},{"key":"3181_CR24","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.bpj.2016.06.016","volume":"111","author":"L Redondo-Morata","year":"2016","unstructured":"Redondo-Morata L, Lea Sanford R, Andersen OS, Scheuring S (2016) Effect of statins on the nanomechanical properties of supported lipid bilayers. Biophys J 111:363\u2013372. https:\/\/doi.org\/10.1016\/j.bpj.2016.06.016","journal-title":"Biophys J"},{"key":"3181_CR25","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1042\/CS20110259","volume":"121","author":"LV Rossoni","year":"2011","unstructured":"Rossoni LV, Wareing M, Wenceslau CF, Al-Abri M, Cobb C, Austin C (2011) Acute simvastatin increases endothelial nitric oxide synthase phosphorylation via AMP-activated protein kinase and reduces contractility of isolated rat mesenteric resistance arteries. Clin Sci 121:449\u2013458. https:\/\/doi.org\/10.1042\/CS20110259","journal-title":"Clin Sci"},{"key":"3181_CR26","doi-asserted-by":"publisher","first-page":"3288","DOI":"10.1093\/cvr\/cvac020","volume":"118","author":"M Ruscica","year":"2022","unstructured":"Ruscica M, Ferri N, Banach M, Sirtori CR, Corsini A (2022) Side effects of statins: from pathophysiology and epidemiology to diagnostic and therapeutic implications. Cardiovasc Res 118:3288\u20133304. https:\/\/doi.org\/10.1093\/cvr\/cvac020","journal-title":"Cardiovasc Res"},{"key":"3181_CR27","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1097\/FJC.0b013e31802f5895","volume":"49","author":"K Shinozaki","year":"2007","unstructured":"Shinozaki K, Nishio Y, Ayajiki K, Yoshida Y, Masada M, Kashiwagi A, Okamura T (2007) Pitavastatin restores vascular dysfunction in insulin-resistant state by inhibiting NAD(P)H oxidase activity and uncoupled endothelial nitric oxide synthase-dependent superoxide production. J Cardiovasc Pharmacol 49:122\u2013130. https:\/\/doi.org\/10.1097\/FJC.0b013e31802f5895","journal-title":"J Cardiovasc Pharmacol"},{"key":"3181_CR28","doi-asserted-by":"publisher","unstructured":"Shvetsova AA, Vlaskina OA, Kabiolskaya SD, Kabiolsky IA, Gaynullina DK (2026) Basic characteristics of systemic arteries of different organs. J Vasc Res 1\u20139. https:\/\/doi.org\/10.1159\/000551138","DOI":"10.1159\/000551138"},{"key":"3181_CR29","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1161\/HYPERTENSIONAHA.109.132258","volume":"53","author":"A Virdis","year":"2009","unstructured":"Virdis A, Colucci R, Versari D, Ghisu N, Fornai M, Antonioli L, Duranti E, Daghini E, Giannarelli C, Blandizzi C, Taddei S, Del Tacca M (2009) Atorvastatin prevents endothelial dysfunction in mesenteric arteries from spontaneously hypertensive rats. Hypertension 53:1008\u20131016. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.109.132258","journal-title":"Hypertension"},{"key":"3181_CR30","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1161\/01.ATV.20.1.61","volume":"20","author":"AH Wagner","year":"2000","unstructured":"Wagner AH, K\u00f6hler T, R\u00fcckschloss U, Just I, Hecker M (2000) Improvement of nitric oxide\u2013dependent vasodilatation by HMG-CoA reductase inhibitors through attenuation of endothelial superoxide anion formation. Arterioscler Thromb Vasc Biol 20:61\u201369. https:\/\/doi.org\/10.1161\/01.ATV.20.1.61","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"3181_CR31","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1161\/01.HYP.37.6.1450","volume":"37","author":"S Wassmann","year":"2001","unstructured":"Wassmann S, Laufs U, B\u00e4umer AT, M\u00fcller K, Ahlbory K, Linz W, Itter G, R\u00f6sen R, B\u00f6hm M, Nickenig G (2001) HMG-CoA Reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen species. Hypertension 37:1450\u20131457. https:\/\/doi.org\/10.1161\/01.HYP.37.6.1450","journal-title":"Hypertension"},{"key":"3181_CR32","doi-asserted-by":"publisher","unstructured":"Zakyrjanova GF, Tsentsevitsky AN, Matigorova VA, Fedorov NS, Odnoshivkina JG, Sibgatullina GV, Kapliukhina EA, Giniatullin AR, Khaziev AN, Malomouzh AI, Gogolev YV, Petrov AM (2025) Cholesterol-lowering treatment suppresses neuromuscular transmission via presynaptic mechanism at the mouse diaphragm muscle. Neurochem Res 50. https:\/\/doi.org\/10.1007\/s11064-025-04550-4","DOI":"10.1007\/s11064-025-04550-4"},{"key":"3181_CR33","doi-asserted-by":"publisher","first-page":"2877","DOI":"10.1007\/s00204-025-04056-6","volume":"99","author":"GF Zakyrjanova","year":"2025","unstructured":"Zakyrjanova GF, Matigorova VA, Kuznetsova EA, Dmitrieva SA, Tyapkina OV, Tsentsevitsky AN, Andreyanova SN, Odnoshivkina JG, Shigapova RR, Mukhamedshina YO, Gogolev YV, Petrov AM (2025) Key genes and processes affected by atorvastatin treatment in mouse diaphragm muscle. Arch Toxicol 99:2877\u20132901. https:\/\/doi.org\/10.1007\/s00204-025-04056-6","journal-title":"Arch Toxicol"},{"key":"3181_CR34","doi-asserted-by":"publisher","first-page":"869","DOI":"10.3760\/cma.j.issn.0366-6999.20131801","volume":"127","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, Dai L, Wu S, Chen P, Zhao S (2014) Atorvastatin attenuates involvement of RhoA\/Rho-kinase pathway and NF-\u03baB activation in hypoxic pulmonary hypertensive rats. Chin Med J (Engl) 127:869\u2013872. https:\/\/doi.org\/10.3760\/cma.j.issn.0366-6999.20131801","journal-title":"Chin Med J (Engl)"}],"container-title":["Pfl\u00fcgers Archiv - European Journal of Physiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00424-026-03181-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00424-026-03181-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00424-026-03181-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T06:55:20Z","timestamp":1781592920000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00424-026-03181-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,20]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["3181"],"URL":"https:\/\/doi.org\/10.1007\/s00424-026-03181-0","relation":{},"ISSN":["0031-6768","1432-2013"],"issn-type":[{"value":"0031-6768","type":"print"},{"value":"1432-2013","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,20]]},"assertion":[{"value":"5 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Animal experiments were carried out in accordance with the EU Directive 2010\/63\/EU and the NIH Guide for the Care and Use of Laboratory Animals. The experimental protocol was approved by the Local Ethical Committee of Kazan Federal Scientific Centre (protocol #25\/4; November 05, 2025).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"49"}}